A citation-based method for searching scientific literature

Daniel I Chasman, Franco Giulianini, Jean MacFadyen, Bryan J Barratt, Fredrik Nyberg, Paul M Ridker. Circ Cardiovasc Genet 2012
Times Cited: 190







List of co-cited articles
1420 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins.
Iris Postmus, Stella Trompet, Harshal A Deshmukh, Michael R Barnes, Xiaohui Li, Helen R Warren, Daniel I Chasman, Kaixin Zhou, Benoit J Arsenault, Louise A Donnelly,[...]. Nat Commun 2014
146
28

SLCO1B1 variants and statin-induced myopathy--a genomewide study.
E Link, S Parish, J Armitage, L Bowman, S Heath, F Matsuda, I Gut, M Lathrop, R Collins. N Engl J Med 2008
26

Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a).
Harshal A Deshmukh, Helen M Colhoun, Toby Johnson, Paul M McKeigue, D John Betteridge, Paul N Durrington, John H Fuller, Shona Livingstone, Valentine Charlton-Menys, Andrew Neil,[...]. J Lipid Res 2012
75
25

Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study.
Jemma C Hopewell, Sarah Parish, Alison Offer, Emma Link, Robert Clarke, Mark Lathrop, Jane Armitage, Rory Collins. Eur Heart J 2013
72
25

Genome-wide association of lipid-lowering response to statins in combined study populations.
Mathew J Barber, Lara M Mangravite, Craig L Hyde, Daniel I Chasman, Joshua D Smith, Catherine A McCarty, Xiaohui Li, Russell A Wilke, Mark J Rieder, Paul T Williams,[...]. PLoS One 2010
173
17

Comprehensive whole-genome and candidate gene analysis for response to statin therapy in the Treating to New Targets (TNT) cohort.
John F Thompson, Craig L Hyde, Linda S Wood, Sara A Paciga, David A Hinds, David R Cox, G Kees Hovingh, John J P Kastelein. Circ Cardiovasc Genet 2009
139
17

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.
C Baigent, L Blackwell, J Emberson, L E Holland, C Reith, N Bhala, R Peto, E H Barnes, A Keech, J Simes,[...]. Lancet 2010
17

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
Paul M Ridker, Eleanor Danielson, Francisco A H Fonseca, Jacques Genest, Antonio M Gotto, John J P Kastelein, Wolfgang Koenig, Peter Libby, Alberto J Lorenzatti, Jean G MacFadyen,[...]. N Engl J Med 2008
16

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.
Marc S Sabatine, Robert P Giugliano, Anthony C Keech, Narimon Honarpour, Stephen D Wiviott, Sabina A Murphy, Julia F Kuder, Huei Wang, Thomas Liu, Scott M Wasserman,[...]. N Engl J Med 2017
16

Effects of polymorphisms in ABCG2, SLCO1B1, SLC10A1 and CYP2C9/19 on plasma concentrations of rosuvastatin and lipid response in Chinese patients.
Hon-Kit Lee, Miao Hu, Sandra Sh Lui, Chung-Shun Ho, Chun-Kwok Wong, Brian Tomlinson. Pharmacogenomics 2013
76
19

Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management.
Erik S Stroes, Paul D Thompson, Alberto Corsini, Georgirene D Vladutiu, Frederick J Raal, Kausik K Ray, Michael Roden, Evan Stein, Lale Tokgözoğlu, Børge G Nordestgaard,[...]. Eur Heart J 2015
715
15

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.
C Baigent, A Keech, P M Kearney, L Blackwell, G Buck, C Pollicino, A Kirby, T Sourjina, R Peto, R Collins,[...]. Lancet 2005
14

The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update.
L B Ramsey, S G Johnson, K E Caudle, C E Haidar, D Voora, R A Wilke, W D Maxwell, H L McLeod, R M Krauss, D M Roden,[...]. Clin Pharmacol Ther 2014
243
13

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.
Christopher P Cannon, Michael A Blazing, Robert P Giugliano, Amy McCagg, Jennifer A White, Pierre Theroux, Harald Darius, Basil S Lewis, Ton Oude Ophuis, J Wouter Jukema,[...]. N Engl J Med 2015
13

Efficacy and safety of alirocumab in reducing lipids and cardiovascular events.
Jennifer G Robinson, Michel Farnier, Michel Krempf, Jean Bergeron, Gérald Luc, Maurizio Averna, Erik S Stroes, Gisle Langslet, Frederick J Raal, Mahfouz El Shahawy,[...]. N Engl J Med 2015
13

ABCG2 polymorphism is associated with the low-density lipoprotein cholesterol response to rosuvastatin.
B Tomlinson, M Hu, V W Y Lee, S S H Lui, T T W Chu, E W M Poon, G T C Ko, L Baum, L S Tam, E K Li. Clin Pharmacol Ther 2010
102
12

Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.
Jonathan C Cohen, Eric Boerwinkle, Thomas H Mosley, Helen H Hobbs. N Engl J Med 2006
12

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
Neil J Stone, Jennifer G Robinson, Alice H Lichtenstein, C Noel Bairey Merz, Conrad B Blum, Robert H Eckel, Anne C Goldberg, David Gordon, Daniel Levy, Donald M Lloyd-Jones,[...]. Circulation 2014
12

Pharmacogenetic study of statin therapy and cholesterol reduction.
Daniel I Chasman, David Posada, Lakshman Subrahmanyan, Nancy R Cook, Vincent P Stanton, Paul M Ridker. JAMA 2004
318
11

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.
B Mihaylova, J Emberson, L Blackwell, A Keech, J Simes, E H Barnes, M Voysey, A Gray, R Collins, C Baigent. Lancet 2012
11

Discovery and refinement of loci associated with lipid levels.
Cristen J Willer, Ellen M Schmidt, Sebanti Sengupta, Gina M Peloso, Stefan Gustafsson, Stavroula Kanoni, Andrea Ganna, Jin Chen, Martin L Buchkovich, Samia Mora,[...]. Nat Genet 2013
11

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias.
Alberico L Catapano, Ian Graham, Guy De Backer, Olov Wiklund, M John Chapman, Heinz Drexel, Arno W Hoes, Catriona S Jennings, Ulf Landmesser, Terje R Pedersen,[...]. Eur Heart J 2016
11

ABCG2 polymorphism markedly affects the pharmacokinetics of atorvastatin and rosuvastatin.
J E Keskitalo, O Zolk, M F Fromm, K J Kurkinen, P J Neuvonen, M Niemi. Clin Pharmacol Ther 2009
271
10

Clinical and pharmacogenetic predictors of circulating atorvastatin and rosuvastatin concentrations in routine clinical care.
Marianne K DeGorter, Rommel G Tirona, Ute I Schwarz, Yun-Hee Choi, George K Dresser, Neville Suskin, Kathryn Myers, GuangYong Zou, Otito Iwuchukwu, Wei-Qi Wei,[...]. Circ Cardiovasc Genet 2013
123
10

A global reference for human genetic variation.
Adam Auton, Lisa D Brooks, Richard M Durbin, Erik P Garrison, Hyun Min Kang, Jan O Korbel, Jonathan L Marchini, Shane McCarthy, Gil A McVean, Gonçalo R Abecasis. Nature 2015
10

Principal components analysis corrects for stratification in genome-wide association studies.
Alkes L Price, Nick J Patterson, Robert M Plenge, Michael E Weinblatt, Nancy A Shadick, David Reich. Nat Genet 2006
9

Clinical implications of pharmacogenomics of statin treatment.
L M Mangravite, C F Thorn, R M Krauss. Pharmacogenomics J 2006
114
9

PLINK: a tool set for whole-genome association and population-based linkage analyses.
Shaun Purcell, Benjamin Neale, Kathe Todd-Brown, Lori Thomas, Manuel A R Ferreira, David Bender, Julian Maller, Pamela Sklar, Paul I W de Bakker, Mark J Daly,[...]. Am J Hum Genet 2007
9

A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease.
Majid Nikpay, Anuj Goel, Hong-Hee Won, Leanne M Hall, Christina Willenborg, Stavroula Kanoni, Danish Saleheen, Theodosios Kyriakou, Christopher P Nelson, Jemma C Hopewell,[...]. Nat Genet 2015
9

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society.
Børge G Nordestgaard, M John Chapman, Steve E Humphries, Henry N Ginsberg, Luis Masana, Olivier S Descamps, Olov Wiklund, Robert A Hegele, Frederick J Raal, Joep C Defesche,[...]. Eur Heart J 2013
9

HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials.
Daniel I Swerdlow, David Preiss, Karoline B Kuchenbaecker, Michael V Holmes, Jorgen E L Engmann, Tina Shah, Reecha Sofat, Stefan Stender, Paul C D Johnson, Robert A Scott,[...]. Lancet 2015
395
9

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia.
Marianne Abifadel, Mathilde Varret, Jean-Pierre Rabès, Delphine Allard, Khadija Ouguerram, Martine Devillers, Corinne Cruaud, Suzanne Benjannet, Louise Wickham, Danièle Erlich,[...]. Nat Genet 2003
9

Efficacy and safety of evolocumab in reducing lipids and cardiovascular events.
Marc S Sabatine, Robert P Giugliano, Stephen D Wiviott, Frederick J Raal, Dirk J Blom, Jennifer Robinson, Christie M Ballantyne, Ransi Somaratne, Jason Legg, Scott M Wasserman,[...]. N Engl J Med 2015
9

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials.
Naveed Sattar, David Preiss, Heather M Murray, Paul Welsh, Brendan M Buckley, Anton J M de Craen, Sreenivasa Rao Kondapally Seshasai, John J McMurray, Dilys J Freeman, J Wouter Jukema,[...]. Lancet 2010
9

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.
François Mach, Colin Baigent, Alberico L Catapano, Konstantinos C Koskinas, Manuela Casula, Lina Badimon, M John Chapman, Guy G De Backer, Victoria Delgado, Brian A Ference,[...]. Eur Heart J 2020
9

Hepatic metabolism and transporter gene variants enhance response to rosuvastatin in patients with acute myocardial infarction: the GEOSTAT-1 Study.
Kristian M Bailey, Simon P R Romaine, Beryl M Jackson, Amanda J Farrin, Maria Efthymiou, Julian H Barth, Joanne Copeland, Terry McCormack, Andrew Whitehead, Marcus D Flather,[...]. Circ Cardiovasc Genet 2010
71
11

Identification of genetic variants associated with response to statin therapy.
Jessica L Mega, David A Morrow, Alison Brown, Christopher P Cannon, Marc S Sabatine. Arterioscler Thromb Vasc Biol 2009
61
13

Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients.
Miao Hu, Sandra S H Lui, Valiant W L Mak, Tanya T W Chu, Vivian W Y Lee, Emily W M Poon, Teresa K C Tsui, Gary T C Ko, Larry Baum, Lai-Shan Tam,[...]. Pharmacogenet Genomics 2010
36
22

The role of common variants of ABCB1, CYP3A4, and CYP3A5 genes in lipid-lowering efficacy and safety of simvastatin treatment.
Marilu Fiegenbaum, Fabiano R da Silveira, Cézar R Van der Sand, Luiz Carlos Van der Sand, Maria E W Ferreira, Renan C Pires, Mara H Hutz. Clin Pharmacol Ther 2005
142
8

A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose.
Fumihiko Takeuchi, Ralph McGinnis, Stephane Bourgeois, Chris Barnes, Niclas Eriksson, Nicole Soranzo, Pamela Whittaker, Venkatesh Ranganath, Vasudev Kumanduri, William McLaren,[...]. PLoS Genet 2009
455
8

Impact of ABCG2 and SLCO1B1 polymorphisms on pharmacokinetics of rosuvastatin, atorvastatin and simvastatin acid in Caucasian and Asian subjects: a class effect?
Bruce K Birmingham, Sarah R Bujac, Robert Elsby, Connie T Azumaya, Cheryl Wei, Yusong Chen, Rogelio Mosqueda-Garcia, Helen J Ambrose. Eur J Clin Pharmacol 2015
86
9

Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials.
S Matthijs Boekholdt, G Kees Hovingh, Samia Mora, Benoit J Arsenault, Pierre Amarenco, Terje R Pedersen, John C LaRosa, David D Waters, David A DeMicco, R John Simes,[...]. J Am Coll Cardiol 2014
362
8

Statins for the primary prevention of cardiovascular disease.
Fiona Taylor, Mark D Huffman, Ana Filipa Macedo, Theresa H M Moore, Margaret Burke, George Davey Smith, Kirsten Ward, Shah Ebrahim. Cochrane Database Syst Rev 2013
768
8

The SLCO1B1*5 genetic variant is associated with statin-induced side effects.
Deepak Voora, Svati H Shah, Ivan Spasojevic, Shazia Ali, Carol R Reed, Benjamin A Salisbury, Geoffrey S Ginsburg. J Am Coll Cardiol 2009
309
8

SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid.
Marja K Pasanen, Mikko Neuvonen, Pertti J Neuvonen, Mikko Niemi. Pharmacogenet Genomics 2006
346
8

Seventeen years of statin pharmacogenetics: a systematic review.
Maarten Leusink, N Charlotte Onland-Moret, Paul I W de Bakker, Anthonius de Boer, Anke H Maitland-van der Zee. Pharmacogenomics 2016
33
24

Interpretation of the evidence for the efficacy and safety of statin therapy.
Rory Collins, Christina Reith, Jonathan Emberson, Jane Armitage, Colin Baigent, Lisa Blackwell, Roger Blumenthal, John Danesh, George Davey Smith, David DeMets,[...]. Lancet 2016
902
8

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel.
Brian A Ference, Henry N Ginsberg, Ian Graham, Kausik K Ray, Chris J Packard, Eric Bruckert, Robert A Hegele, Ronald M Krauss, Frederick J Raal, Heribert Schunkert,[...]. Eur Heart J 2017
8

Variation in the 3-hydroxyl-3-methylglutaryl coenzyme a reductase gene is associated with racial differences in low-density lipoprotein cholesterol response to simvastatin treatment.
Ronald M Krauss, Lara M Mangravite, Joshua D Smith, Marisa W Medina, Dai Wang, Xiuqing Guo, Mark J Rieder, Joel A Simon, Steven B Hulley, David Waters,[...]. Circulation 2008
114
7

Genetic variation at the LDL receptor and HMG-CoA reductase gene loci, lipid levels, statin response, and cardiovascular disease incidence in PROSPER.
Eliana Polisecki, Hind Muallem, Nobuyo Maeda, Inga Peter, Michele Robertson, Alex D McMahon, Ian Ford, Christopher Packard, James Shepherd, J Wouter Jukema,[...]. Atherosclerosis 2008
55
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.